Publication | Closed Access

Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction

Phosphodiesterase Type 5Vascular DiseaseUrologyCardiovascular DiseaseErectile DysfunctionMedicinePhysiologyVascular BiologyPharmacologyAngiogenic CellsAtherosclerosis